Raising awareness of hormone health is a team effort. ESE and the ESE Foundation are grateful to everyone who is joining us to make World Hormone Day a success.
In particular, we would like to thank our industry supporters for their generous support:
Camurus is a Swedish science-led pharmaceutical company committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic diseases.
M Events is a market leader in conference management technology, offering an all-in-one cloud-based platform and onsite production services for seamless event execution, specialising in scientific conferences.
Recordati Rare Diseases provides urgently needed medicines to reduce the impact of rare and devasting diseases. They believe that each person with a rare disease has the right to the best treatment, and are dedicated to providing this across a range of therapeutic areas including endocrinology, oncology-hematology and metabolic disorders.
BridgeBio has a mission to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases, including Autosomal Dominant Hypocalcemia type 1 (ADH1). ADH1 is a common form of genetic hypoparathyroidism. Calcilytix Therapeutics, an affiliate of BridgeBio, is investigating potential new treatments for ADH1.
